Healthcare - Biotechnology - NASDAQ - US
$ 20.43
-7.56 %
$ 306 M
Market Cap
-4.3
P/E
INCOME STATEMENT
0
REVENUE
-68.9 M
OPERATING INCOME
-64.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Jasper Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 1.11 M |
| Gross Profit | -1.11 M |
| Operating Expenses | 68.9 M |
| Operating Income | -68.9 M |
| Other Expenses | -4.4 M |
| Net Income | -64.5 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 1.1 | 1.3 | 0.6 | 21 K | 0 |
| Gross Profit | (1.1) | (1.3) | (0.6) | 21 K | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 68.9 | 51.2 | 36.8 | 20.7 | 4.5 |
| Selling, General and Administrative Expenses | 17.1 | 16.6 | 11.4 | 4.8 | 1.1 |
| Research and Development Expenses | 51.8 | 34.6 | 25.4 | 15.9 | 3.6 |
| Operating Income | (68.9) | (51.2) | (36.8) | (20.7) | (4.7) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | (13.5) | 0 | 0 | 0 |
| Total Other Income | 2.8 | 13.5 | 6.2 | (11.0) | (0.3) |
| Pre-Tax Income | (66.1) | (37.7) | (30.6) | (31.7) | (5.0) |
| NET INCOME | |||||
| Tax Provision | (1.6) | (13.5) | (6.7) | 38.5 K | 277 |
| Net Income | (64.5) | (24.2) | (24.0) | (31.7) | (5.0) |
| EPS | 6.18 | 6.63 | 21.1 | 114 | 0 |